
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Novartis announced the launch of its FocalView app, an ophthalmic digital research platform created with ResearchKit. This app is designed to collect data directly from patients in order to track disease protection and allow them to particpiate in ophthalmology clinical trials from home.
Read the full release






